Agios Pharmaceuticals reported $0 in Trade Creditors for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acceleron Pharma XLRN:US $ 12M 9M
Alnylam Pharmaceuticals ALNY:US $ 27.87M 1.75M
Amgen AMGN:US $ 1150M 188M
Bayer BAYN:GR 509.8M 23.3M
Biogen BIIB:US $ 398.4M 14.5M
Bluebird Bio BLUE:US $ 26.18M 4.35M
Bristol Myers Squibb BMY:US $ 2852M 217M
Daiichi Sankyo 4568:JP Y 1253M 3104M
Eli Lilly And LLY:US $ 1247.2M 39.5M
Exelixis EXEL:US $ 9M 6M
Gilead Sciences GILD:US $ 532M 58M
Immunogen IMGN:US $ 8.91M 3.83M
JAZZ PHA JAZZ:US $ 67.06M 17.02M
Merk MRK:US $ 3448M 124M
Novartis NOVN:VX 4.82B 8M
Novartis NVS:US $ 4705M 115M
Pfizer PFE:US $ 3872M 100M
Puma Biotechnology PBYI:US $ 11M 6M
Regeneron Pharmaceuticals REGN:US $ 380.1M 32.3M
Sarepta Therapeutics SRPT:US $ 91M 65M
Seattle Genetics SGEN:US $ 68.65M 9.42M
Vertex Pharmaceuticals VRTX:US $ 101.45M 0.75M
YTE INCY:US $ 90.91M 29.97M